Atherectomy Devices Market Size, A Comprehensive Outlook and Forecast for 2026-2035
Ngày đăng: 24-07-2026 |
Ngày cập nhật: 24-07-2026
The global atherectomy devices market was valued at USD 1.1 billion in 2025 and is projected to reach USD 2.5 billion by the end of 2035, expanding at a CAGR of 8.5% during the forecast period (2026–2035). The market is experiencing steady growth due to the increasing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD), rising adoption of minimally invasive vascular interventions, and continuous technological advancements in plaque removal systems. Growing awareness of early diagnosis, expanding healthcare infrastructure, and favorable clinical outcomes associated with atherectomy procedures are also supporting long-term market expansion.
Request Sample @ https://www.researchnester.com/sample-request-8102
Atherectomy Devices Industry Demand
The atherectomy devices market comprises specialized medical devices used to remove atherosclerotic plaque from blood vessels during minimally invasive vascular procedures. These devices help restore blood flow by excising, sanding, vaporizing, or ablating plaque deposits without requiring open surgery. Atherectomy procedures are commonly performed in patients with peripheral artery disease, coronary artery disease, and heavily calcified arterial lesions where conventional angioplasty alone may be less effective.
Demand for atherectomy devices is increasing as healthcare providers increasingly prefer minimally invasive treatment approaches that reduce hospital stays, shorten recovery times, and improve procedural precision. The growing aging population, rising incidence of diabetes, hypertension, obesity, and cardiovascular disorders are significantly expanding the patient pool requiring vascular interventions.
From a healthcare perspective, atherectomy devices contribute to cost-effective treatment by reducing procedural complications, limiting the need for repeat interventions, and enabling faster patient recovery. Their minimally invasive nature simplifies post-procedure management and allows many patients to resume normal activities sooner than traditional surgical approaches. Continuous innovation in catheter design, imaging integration, and plaque modification technologies is further improving procedural efficiency and supporting broader clinical adoption.
Atherectomy Devices Market: Growth Drivers & Key Restraint
Growth Drivers –
Rising Burden of Peripheral and Coronary Artery Diseases
The increasing prevalence of cardiovascular diseases remains the primary growth driver for the atherectomy devices market. Growing numbers of patients suffering from peripheral artery disease, coronary artery disease, diabetes, hypertension, and obesity continue increasing demand for effective plaque removal technologies. As life expectancy rises, healthcare systems are witnessing greater demand for vascular interventions that improve blood circulation while minimizing surgical risks.
Growing Preference for Minimally Invasive Procedures
Healthcare providers are increasingly adopting minimally invasive endovascular procedures due to their ability to reduce hospitalization time, minimize patient discomfort, lower complication risks, and accelerate recovery. Atherectomy devices have become an important component of these procedures by enabling physicians to effectively treat complex and calcified lesions while preserving healthy vessel structures.
Continuous Technological Advancements in Vascular Intervention
Ongoing innovation in atherectomy systems is improving procedural accuracy, safety, and clinical outcomes. Enhanced catheter flexibility, better plaque removal mechanisms, advanced imaging guidance, and improved compatibility with adjunctive therapies have expanded the range of patients eligible for atherectomy procedures. These technological improvements continue encouraging wider adoption among interventional specialists.
Restraint –
Despite favorable clinical outcomes, atherectomy procedures remain relatively expensive due to specialized equipment, advanced catheter technologies, and the requirement for highly trained interventional physicians. In addition, procedural complexity, reimbursement variability, and the availability of alternative treatment options such as angioplasty and stenting may limit broader adoption in certain healthcare settings.
Atherectomy Devices Market: Segment Analysis
Segment Analysis by Product Type –
Directional Atherectomy Devices
Directional atherectomy devices represent a significant segment of the market due to their ability to precisely remove plaque while preserving healthy vessel tissue. These devices are widely used for treating peripheral arterial lesions where controlled plaque excision is required. Continuous technological improvements and growing physician familiarity continue supporting demand.
Rotational Atherectomy Devices
Rotational atherectomy devices maintain strong market demand, particularly for heavily calcified coronary lesions. These systems utilize high-speed rotating burrs to modify hardened plaque before balloon angioplasty or stent placement. Their effectiveness in treating complex lesions contributes to consistent clinical adoption.
Orbital Atherectomy Devices
Orbital atherectomy devices continue gaining acceptance because they provide effective plaque modification while minimizing vessel trauma. Their ability to treat varying vessel diameters with a single device makes them attractive for managing calcified peripheral and coronary lesions. Increasing use in complex vascular interventions supports segment growth.
Laser Atherectomy Devices
Laser atherectomy devices are increasingly utilized for treating difficult vascular blockages through photoablation technology. These systems are particularly valuable in selected lesion types where precise plaque vaporization is beneficial. Continuous advancements in laser energy delivery and catheter technology continue expanding their clinical applications.
Segment Analysis by Application –
Peripheral Artery Disease (PAD)
Peripheral artery disease represents the leading application area for atherectomy devices due to the increasing prevalence of lower limb arterial blockages. Physicians frequently utilize atherectomy to improve blood flow, reduce symptoms, and prepare vessels for additional endovascular treatments.
Coronary Artery Disease (CAD)
Coronary artery disease remains an important application segment as atherectomy devices assist in treating heavily calcified coronary arteries that may be difficult to manage using conventional balloon angioplasty alone. Improved procedural outcomes continue supporting adoption in interventional cardiology.
Neurovascular Interventions
Although representing a smaller portion of the market, neurovascular applications are gaining attention as technological advancements improve precision and safety during highly specialized vascular procedures.
Other Vascular Applications
Additional applications include treatment of complex vascular lesions in specialized clinical settings where plaque modification enhances procedural success and long-term vessel patency.
Segment Analysis by End‑User –
Hospitals
Hospitals account for the largest share of atherectomy device utilization due to the availability of advanced catheterization laboratories, experienced interventional specialists, and comprehensive cardiovascular care facilities. Most complex vascular procedures are performed within hospital settings.
Ambulatory Surgical Centers (ASCs)
Ambulatory Surgical Centers are witnessing increasing adoption of atherectomy procedures as minimally invasive technologies enable same-day treatment and faster patient discharge. Growing demand for outpatient vascular interventions supports this segment.
Catheterization Laboratories
Catheterization laboratories play a central role in performing coronary and peripheral vascular procedures. Continuous investments in advanced imaging systems and endovascular technologies continue strengthening demand for atherectomy devices within these facilities.
Specialty Clinics
Specialty cardiovascular and vascular clinics contribute to market growth by providing focused treatment for peripheral vascular diseases. Increasing availability of minimally invasive therapies in specialized outpatient settings continues expanding patient access.
Atherectomy Devices Market: Regional Insights
North America
North America remains the largest regional market due to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, widespread availability of advanced vascular intervention technologies, and favorable adoption of minimally invasive procedures. Strong clinical research activity and growing awareness of peripheral artery disease continue supporting regional demand.
Europe
Europe represents a mature atherectomy devices market supported by advanced healthcare systems, increasing aging populations, and rising incidence of vascular disorders. Growing preference for minimally invasive cardiovascular treatments, favorable reimbursement in several countries, and continuous technological adoption contribute to sustained market expansion.
Asia-Pacific (APAC)
Asia-Pacific is expected to witness the fastest growth throughout the forecast period. Rising healthcare expenditure, improving hospital infrastructure, expanding access to advanced cardiovascular treatments, increasing prevalence of diabetes and peripheral artery disease, and growing awareness of minimally invasive interventions are creating significant opportunities for atherectomy device manufacturers across the region.
Top Players in the Atherectomy Devices Market
The global atherectomy devices market is characterized by continuous technological innovation, strategic product development, and expanding clinical adoption. Major companies operating in the market include Boston Scientific (U.S.), BD (U.S.), Cardiovascular Systems, Inc. (U.S.), Ra Medical Systems (U.S.), Avinger, Inc. (U.S.), Straub Medical AG (Switzerland), and Rex Medical, L.P. (U.S.). These manufacturers compete through ongoing investments in research and development, advanced catheter technologies, product portfolio expansion, regulatory approvals, strategic collaborations with healthcare providers, and geographic expansion to strengthen their positions in the growing market for minimally invasive vascular intervention devices.
Access Detailed Report @ https://www.researchnester.com/reports/atherectomy-devices-market/8102
Research Nester Analytics is a leading service provider for strategic market research and consulting. We provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives make informed decisions regarding future marketing strategy, expansion, and investments. We believe every business can expand its horizon with the right guidance at the right time. Our out-of-the-box thinking helps clients navigate future uncertainties and market dynamics.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
Request Sample @ https://www.researchnester.com/sample-request-8102
Atherectomy Devices Industry Demand
The atherectomy devices market comprises specialized medical devices used to remove atherosclerotic plaque from blood vessels during minimally invasive vascular procedures. These devices help restore blood flow by excising, sanding, vaporizing, or ablating plaque deposits without requiring open surgery. Atherectomy procedures are commonly performed in patients with peripheral artery disease, coronary artery disease, and heavily calcified arterial lesions where conventional angioplasty alone may be less effective.
Demand for atherectomy devices is increasing as healthcare providers increasingly prefer minimally invasive treatment approaches that reduce hospital stays, shorten recovery times, and improve procedural precision. The growing aging population, rising incidence of diabetes, hypertension, obesity, and cardiovascular disorders are significantly expanding the patient pool requiring vascular interventions.
From a healthcare perspective, atherectomy devices contribute to cost-effective treatment by reducing procedural complications, limiting the need for repeat interventions, and enabling faster patient recovery. Their minimally invasive nature simplifies post-procedure management and allows many patients to resume normal activities sooner than traditional surgical approaches. Continuous innovation in catheter design, imaging integration, and plaque modification technologies is further improving procedural efficiency and supporting broader clinical adoption.
Atherectomy Devices Market: Growth Drivers & Key Restraint
Growth Drivers –
Rising Burden of Peripheral and Coronary Artery Diseases
The increasing prevalence of cardiovascular diseases remains the primary growth driver for the atherectomy devices market. Growing numbers of patients suffering from peripheral artery disease, coronary artery disease, diabetes, hypertension, and obesity continue increasing demand for effective plaque removal technologies. As life expectancy rises, healthcare systems are witnessing greater demand for vascular interventions that improve blood circulation while minimizing surgical risks.
Growing Preference for Minimally Invasive Procedures
Healthcare providers are increasingly adopting minimally invasive endovascular procedures due to their ability to reduce hospitalization time, minimize patient discomfort, lower complication risks, and accelerate recovery. Atherectomy devices have become an important component of these procedures by enabling physicians to effectively treat complex and calcified lesions while preserving healthy vessel structures.
Continuous Technological Advancements in Vascular Intervention
Ongoing innovation in atherectomy systems is improving procedural accuracy, safety, and clinical outcomes. Enhanced catheter flexibility, better plaque removal mechanisms, advanced imaging guidance, and improved compatibility with adjunctive therapies have expanded the range of patients eligible for atherectomy procedures. These technological improvements continue encouraging wider adoption among interventional specialists.
Restraint –
Despite favorable clinical outcomes, atherectomy procedures remain relatively expensive due to specialized equipment, advanced catheter technologies, and the requirement for highly trained interventional physicians. In addition, procedural complexity, reimbursement variability, and the availability of alternative treatment options such as angioplasty and stenting may limit broader adoption in certain healthcare settings.
Atherectomy Devices Market: Segment Analysis
Segment Analysis by Product Type –
Directional Atherectomy Devices
Directional atherectomy devices represent a significant segment of the market due to their ability to precisely remove plaque while preserving healthy vessel tissue. These devices are widely used for treating peripheral arterial lesions where controlled plaque excision is required. Continuous technological improvements and growing physician familiarity continue supporting demand.
Rotational Atherectomy Devices
Rotational atherectomy devices maintain strong market demand, particularly for heavily calcified coronary lesions. These systems utilize high-speed rotating burrs to modify hardened plaque before balloon angioplasty or stent placement. Their effectiveness in treating complex lesions contributes to consistent clinical adoption.
Orbital Atherectomy Devices
Orbital atherectomy devices continue gaining acceptance because they provide effective plaque modification while minimizing vessel trauma. Their ability to treat varying vessel diameters with a single device makes them attractive for managing calcified peripheral and coronary lesions. Increasing use in complex vascular interventions supports segment growth.
Laser Atherectomy Devices
Laser atherectomy devices are increasingly utilized for treating difficult vascular blockages through photoablation technology. These systems are particularly valuable in selected lesion types where precise plaque vaporization is beneficial. Continuous advancements in laser energy delivery and catheter technology continue expanding their clinical applications.
Segment Analysis by Application –
Peripheral Artery Disease (PAD)
Peripheral artery disease represents the leading application area for atherectomy devices due to the increasing prevalence of lower limb arterial blockages. Physicians frequently utilize atherectomy to improve blood flow, reduce symptoms, and prepare vessels for additional endovascular treatments.
Coronary Artery Disease (CAD)
Coronary artery disease remains an important application segment as atherectomy devices assist in treating heavily calcified coronary arteries that may be difficult to manage using conventional balloon angioplasty alone. Improved procedural outcomes continue supporting adoption in interventional cardiology.
Neurovascular Interventions
Although representing a smaller portion of the market, neurovascular applications are gaining attention as technological advancements improve precision and safety during highly specialized vascular procedures.
Other Vascular Applications
Additional applications include treatment of complex vascular lesions in specialized clinical settings where plaque modification enhances procedural success and long-term vessel patency.
Segment Analysis by End‑User –
Hospitals
Hospitals account for the largest share of atherectomy device utilization due to the availability of advanced catheterization laboratories, experienced interventional specialists, and comprehensive cardiovascular care facilities. Most complex vascular procedures are performed within hospital settings.
Ambulatory Surgical Centers (ASCs)
Ambulatory Surgical Centers are witnessing increasing adoption of atherectomy procedures as minimally invasive technologies enable same-day treatment and faster patient discharge. Growing demand for outpatient vascular interventions supports this segment.
Catheterization Laboratories
Catheterization laboratories play a central role in performing coronary and peripheral vascular procedures. Continuous investments in advanced imaging systems and endovascular technologies continue strengthening demand for atherectomy devices within these facilities.
Specialty Clinics
Specialty cardiovascular and vascular clinics contribute to market growth by providing focused treatment for peripheral vascular diseases. Increasing availability of minimally invasive therapies in specialized outpatient settings continues expanding patient access.
Atherectomy Devices Market: Regional Insights
North America
North America remains the largest regional market due to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, widespread availability of advanced vascular intervention technologies, and favorable adoption of minimally invasive procedures. Strong clinical research activity and growing awareness of peripheral artery disease continue supporting regional demand.
Europe
Europe represents a mature atherectomy devices market supported by advanced healthcare systems, increasing aging populations, and rising incidence of vascular disorders. Growing preference for minimally invasive cardiovascular treatments, favorable reimbursement in several countries, and continuous technological adoption contribute to sustained market expansion.
Asia-Pacific (APAC)
Asia-Pacific is expected to witness the fastest growth throughout the forecast period. Rising healthcare expenditure, improving hospital infrastructure, expanding access to advanced cardiovascular treatments, increasing prevalence of diabetes and peripheral artery disease, and growing awareness of minimally invasive interventions are creating significant opportunities for atherectomy device manufacturers across the region.
Top Players in the Atherectomy Devices Market
The global atherectomy devices market is characterized by continuous technological innovation, strategic product development, and expanding clinical adoption. Major companies operating in the market include Boston Scientific (U.S.), BD (U.S.), Cardiovascular Systems, Inc. (U.S.), Ra Medical Systems (U.S.), Avinger, Inc. (U.S.), Straub Medical AG (Switzerland), and Rex Medical, L.P. (U.S.). These manufacturers compete through ongoing investments in research and development, advanced catheter technologies, product portfolio expansion, regulatory approvals, strategic collaborations with healthcare providers, and geographic expansion to strengthen their positions in the growing market for minimally invasive vascular intervention devices.
Access Detailed Report @ https://www.researchnester.com/reports/atherectomy-devices-market/8102
Research Nester Analytics is a leading service provider for strategic market research and consulting. We provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives make informed decisions regarding future marketing strategy, expansion, and investments. We believe every business can expand its horizon with the right guidance at the right time. Our out-of-the-box thinking helps clients navigate future uncertainties and market dynamics.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
